Gene Symbol | Gene ID | Gene Info |
---|---|---|
Mnt
|
ENSMUSG00000000282.6 | max binding protein |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_74820791_74820951 | Mnt | 10049 | 0.125235 | -0.85 | 3.2e-02 | Click! |
chr11_74829084_74829235 | Mnt | 1761 | 0.251448 | -0.77 | 7.5e-02 | Click! |
chr11_74823491_74823642 | Mnt | 7354 | 0.130316 | -0.73 | 1.0e-01 | Click! |
chr11_74832185_74832347 | Mnt | 1346 | 0.319080 | 0.68 | 1.4e-01 | Click! |
chr11_74821059_74821337 | Mnt | 9722 | 0.125719 | 0.67 | 1.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_145056434_145056606 | 21.06 |
Gm45181 |
predicted gene 45181 |
106476 |
0.05 |
chr3_130853480_130853631 | 13.55 |
Gm5982 |
predicted gene 5982 |
6582 |
0.12 |
chr13_59011529_59011736 | 13.27 |
Gm34245 |
predicted gene, 34245 |
66664 |
0.09 |
chr4_124005727_124005878 | 12.71 |
Gm12902 |
predicted gene 12902 |
79568 |
0.07 |
chr6_112939448_112939605 | 11.43 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
7228 |
0.15 |
chr14_61125286_61125469 | 11.39 |
Sacs |
sacsin |
13080 |
0.21 |
chr5_8157542_8157699 | 10.86 |
Gm21759 |
predicted gene, 21759 |
22016 |
0.16 |
chr1_40217644_40217810 | 10.58 |
Il1r1 |
interleukin 1 receptor, type I |
7353 |
0.21 |
chr12_71429918_71430089 | 10.54 |
1700083H02Rik |
RIKEN cDNA 1700083H02 gene |
45795 |
0.12 |
chr11_118265609_118265912 | 10.42 |
Usp36 |
ubiquitin specific peptidase 36 |
288 |
0.89 |
chr11_55468108_55468290 | 9.63 |
G3bp1 |
GTPase activating protein (SH3 domain) binding protein 1 |
1486 |
0.25 |
chr6_90772172_90772486 | 9.55 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
8188 |
0.18 |
chr6_99145207_99145385 | 9.49 |
Foxp1 |
forkhead box P1 |
17722 |
0.26 |
chr10_80323047_80323198 | 9.46 |
Pcsk4 |
proprotein convertase subtilisin/kexin type 4 |
4 |
0.93 |
chr6_91599085_91599288 | 9.16 |
Gm45218 |
predicted gene 45218 |
46 |
0.97 |
chr6_86129871_86130022 | 9.08 |
Gm19596 |
predicted gene, 19596 |
17206 |
0.14 |
chr7_25220574_25220762 | 8.92 |
Dedd2 |
death effector domain-containing DNA binding protein 2 |
53 |
0.89 |
chr19_33489637_33489788 | 8.68 |
Lipo5 |
lipase, member O5 |
16521 |
0.14 |
chr17_56476460_56476653 | 8.57 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
73 |
0.96 |
chr19_33480626_33480777 | 8.57 |
Lipo5 |
lipase, member O5 |
7510 |
0.16 |
chr11_61974443_61974594 | 8.46 |
Gm12274 |
predicted gene 12274 |
168 |
0.92 |
chr15_77236066_77236232 | 8.17 |
Gm24056 |
predicted gene, 24056 |
6402 |
0.17 |
chr4_124670340_124670505 | 8.13 |
Gm2164 |
predicted gene 2164 |
13253 |
0.09 |
chr2_21211497_21211673 | 7.98 |
Thnsl1 |
threonine synthase-like 1 (bacterial) |
5798 |
0.17 |
chr3_65663297_65663473 | 7.96 |
Lekr1 |
leucine, glutamate and lysine rich 1 |
2843 |
0.19 |
chr17_47329074_47329231 | 7.88 |
Trerf1 |
transcriptional regulating factor 1 |
35083 |
0.1 |
chr1_88316757_88316908 | 7.82 |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
2081 |
0.23 |
chr13_37468607_37468985 | 7.80 |
Gm47731 |
predicted gene, 47731 |
3242 |
0.13 |
chr7_45710445_45711101 | 7.65 |
Sphk2 |
sphingosine kinase 2 |
2670 |
0.09 |
chr12_3835711_3835863 | 7.60 |
Dnmt3a |
DNA methyltransferase 3A |
13848 |
0.17 |
chr19_5028205_5028356 | 7.51 |
Slc29a2 |
solute carrier family 29 (nucleoside transporters), member 2 |
2103 |
0.12 |
chr8_46385009_46385281 | 7.50 |
Gm45253 |
predicted gene 45253 |
743 |
0.6 |
chr5_139320505_139320656 | 7.48 |
Adap1 |
ArfGAP with dual PH domains 1 |
5042 |
0.14 |
chr15_84121144_84121320 | 7.36 |
Pnpla5 |
patatin-like phospholipase domain containing 5 |
1943 |
0.2 |
chr11_63703995_63704169 | 7.34 |
Gm12287 |
predicted gene 12287 |
103159 |
0.07 |
chr2_71032072_71032241 | 7.27 |
Mettl8 |
methyltransferase like 8 |
13778 |
0.2 |
chr9_25520943_25521129 | 7.21 |
Gm25861 |
predicted gene, 25861 |
18169 |
0.18 |
chr15_83471603_83471756 | 7.12 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
7073 |
0.15 |
chr2_48442189_48442365 | 7.10 |
Gm13481 |
predicted gene 13481 |
14968 |
0.23 |
chr8_77369753_77369904 | 7.08 |
Gm45407 |
predicted gene 45407 |
2688 |
0.28 |
chr13_31619653_31619819 | 7.03 |
Gm11378 |
predicted gene 11378 |
568 |
0.66 |
chr5_146967227_146967378 | 6.78 |
Mtif3 |
mitochondrial translational initiation factor 3 |
3502 |
0.21 |
chr4_128946816_128947003 | 6.70 |
Gm15904 |
predicted gene 15904 |
10904 |
0.15 |
chr5_73474533_73474709 | 6.60 |
Gm15653 |
predicted gene 15653 |
2732 |
0.2 |
chr8_114155454_114155605 | 6.57 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
21887 |
0.24 |
chr6_87424500_87424651 | 6.50 |
Bmp10 |
bone morphogenetic protein 10 |
4419 |
0.16 |
chr5_113204337_113204488 | 6.48 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
16824 |
0.12 |
chr2_172511032_172511203 | 6.48 |
Gm14303 |
predicted gene 14303 |
1426 |
0.37 |
chr4_107999051_107999218 | 6.47 |
Slc1a7 |
solute carrier family 1 (glutamate transporter), member 7 |
10883 |
0.13 |
chr2_6611640_6611812 | 6.39 |
Celf2 |
CUGBP, Elav-like family member 2 |
4454 |
0.32 |
chr7_3704520_3704711 | 6.37 |
Rps9 |
ribosomal protein S9 |
251 |
0.8 |
chr11_97958258_97958415 | 6.36 |
Gm11633 |
predicted gene 11633 |
10456 |
0.1 |
chr18_60922022_60922173 | 6.28 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
3521 |
0.17 |
chr2_172620477_172620628 | 6.24 |
Tfap2c |
transcription factor AP-2, gamma |
68436 |
0.1 |
chr1_186358132_186358570 | 6.24 |
Gm37491 |
predicted gene, 37491 |
11036 |
0.28 |
chr7_45574063_45574214 | 6.24 |
Bcat2 |
branched chain aminotransferase 2, mitochondrial |
962 |
0.22 |
chr4_88546855_88547012 | 6.23 |
Ifna15 |
interferon alpha 15 |
11312 |
0.1 |
chr8_114090720_114090885 | 6.05 |
Nudt7 |
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
42755 |
0.2 |
chr6_86193078_86193250 | 6.03 |
Tgfa |
transforming growth factor alpha |
2059 |
0.28 |
chr10_80966373_80966536 | 6.01 |
Gm3828 |
predicted gene 3828 |
11744 |
0.09 |
chr4_55750335_55750505 | 5.99 |
Gm12506 |
predicted gene 12506 |
145271 |
0.04 |
chr5_113152964_113153205 | 5.98 |
Gm42161 |
predicted gene, 42161 |
7756 |
0.11 |
chr13_56692137_56692672 | 5.98 |
Smad5 |
SMAD family member 5 |
10606 |
0.22 |
chr4_141347370_141347546 | 5.94 |
Gm13074 |
predicted gene 13074 |
356 |
0.71 |
chr10_95616861_95617023 | 5.90 |
Gm33336 |
predicted gene, 33336 |
15297 |
0.12 |
chr12_108316971_108317122 | 5.89 |
Hhipl1 |
hedgehog interacting protein-like 1 |
10498 |
0.15 |
chr8_26882732_26882894 | 5.86 |
2310008N11Rik |
RIKEN cDNA 2310008N11 gene |
118 |
0.97 |
chr13_113168060_113168232 | 5.85 |
Gzmk |
granzyme K |
12751 |
0.12 |
chr3_9599812_9599994 | 5.82 |
Zfp704 |
zinc finger protein 704 |
10182 |
0.23 |
chr3_53000130_53000284 | 5.81 |
Cog6 |
component of oligomeric golgi complex 6 |
5522 |
0.16 |
chr11_121250287_121250476 | 5.79 |
Narf |
nuclear prelamin A recognition factor |
5361 |
0.13 |
chr7_130044668_130044823 | 5.70 |
Gm23847 |
predicted gene, 23847 |
9651 |
0.28 |
chr6_54760026_54760215 | 5.67 |
Znrf2 |
zinc and ring finger 2 |
56796 |
0.1 |
chr10_19443595_19443775 | 5.66 |
Gm33104 |
predicted gene, 33104 |
43030 |
0.15 |
chr19_3707659_3707822 | 5.65 |
Gm36608 |
predicted gene, 36608 |
436 |
0.49 |
chr18_84376797_84376986 | 5.62 |
Gm37216 |
predicted gene, 37216 |
745 |
0.73 |
chr18_34865102_34865266 | 5.61 |
Egr1 |
early growth response 1 |
3977 |
0.17 |
chr2_68873804_68874167 | 5.49 |
Cers6 |
ceramide synthase 6 |
12399 |
0.14 |
chr6_121185382_121185551 | 5.47 |
Pex26 |
peroxisomal biogenesis factor 26 |
1568 |
0.29 |
chr5_107272215_107272373 | 5.44 |
Gm42900 |
predicted gene 42900 |
15790 |
0.13 |
chr4_150119850_150120001 | 5.44 |
Slc2a5 |
solute carrier family 2 (facilitated glucose transporter), member 5 |
642 |
0.38 |
chr12_79354783_79354941 | 5.39 |
Rad51b |
RAD51 paralog B |
27509 |
0.19 |
chr3_90473370_90473521 | 5.37 |
Gm43595 |
predicted gene 43595 |
2486 |
0.12 |
chr17_47089532_47089710 | 5.37 |
Gm4945 |
predicted gene 4945 |
46582 |
0.12 |
chr17_45825973_45826124 | 5.36 |
Gm35692 |
predicted gene, 35692 |
3725 |
0.21 |
chr2_173531317_173531484 | 5.36 |
1700021F07Rik |
RIKEN cDNA 1700021F07 gene |
8814 |
0.21 |
chr3_89149809_89149960 | 5.29 |
Hcn3 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 3 |
1330 |
0.2 |
chr13_48916144_48916308 | 5.29 |
Phf2 |
PHD finger protein 2 |
45107 |
0.13 |
chr1_164471743_164471894 | 5.21 |
Gm32391 |
predicted gene, 32391 |
9376 |
0.14 |
chr2_129582795_129582946 | 5.18 |
Sirpa |
signal-regulatory protein alpha |
9965 |
0.17 |
chr2_35233951_35234102 | 5.16 |
Gm13605 |
predicted gene 13605 |
9493 |
0.14 |
chr11_55126402_55126555 | 5.11 |
Mup-ps22 |
major urinary protein, pseudogene 22 |
2783 |
0.16 |
chr1_157077432_157077585 | 5.07 |
Gm28694 |
predicted gene 28694 |
23474 |
0.14 |
chr9_44320850_44321043 | 5.06 |
C2cd2l |
C2 calcium-dependent domain containing 2-like |
661 |
0.38 |
chr15_81523272_81523474 | 5.06 |
Gm5218 |
predicted gene 5218 |
23828 |
0.11 |
chr16_17802864_17803015 | 5.03 |
Scarf2 |
scavenger receptor class F, member 2 |
463 |
0.67 |
chr16_77332289_77332458 | 5.00 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2869 |
0.23 |
chr15_77236258_77236509 | 5.00 |
Gm24056 |
predicted gene, 24056 |
6168 |
0.17 |
chr16_4303663_4303819 | 4.96 |
Gm6142 |
predicted pseudogene 6142 |
16939 |
0.19 |
chr8_77044937_77045106 | 4.93 |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
82992 |
0.09 |
chr16_21329295_21329453 | 4.93 |
Magef1 |
melanoma antigen family F, 1 |
3755 |
0.23 |
chr10_75835336_75835679 | 4.91 |
Gstt2 |
glutathione S-transferase, theta 2 |
626 |
0.54 |
chr2_33444601_33444770 | 4.88 |
Gm13536 |
predicted gene 13536 |
2117 |
0.25 |
chr2_7260244_7260638 | 4.87 |
Gm24340 |
predicted gene, 24340 |
89656 |
0.09 |
chr3_104358852_104359020 | 4.86 |
Gm5546 |
predicted gene 5546 |
7677 |
0.18 |
chr11_115212363_115212520 | 4.86 |
Nat9 |
N-acetyltransferase 9 (GCN5-related, putative) |
24582 |
0.09 |
chr14_30934111_30934339 | 4.81 |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
9052 |
0.1 |
chrX_103326968_103327154 | 4.81 |
Cdx4 |
caudal type homeobox 4 |
5663 |
0.1 |
chr6_117577945_117578096 | 4.80 |
Gm9946 |
predicted gene 9946 |
10348 |
0.2 |
chr13_113168399_113168569 | 4.80 |
Gzmk |
granzyme K |
12413 |
0.12 |
chr3_10174352_10174597 | 4.80 |
Pmp2 |
peripheral myelin protein 2 |
9455 |
0.12 |
chr2_101831932_101832083 | 4.79 |
Prr5l |
proline rich 5 like |
6973 |
0.23 |
chr11_115249882_115250043 | 4.76 |
Gm25837 |
predicted gene, 25837 |
3316 |
0.14 |
chr13_109559884_109560099 | 4.76 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
21414 |
0.29 |
chr11_16868200_16868447 | 4.75 |
Egfr |
epidermal growth factor receptor |
9827 |
0.2 |
chr17_4479666_4479822 | 4.72 |
4930517M08Rik |
RIKEN cDNA 4930517M08 gene |
155234 |
0.04 |
chr6_91424316_91424467 | 4.71 |
Gm4575 |
predicted gene 4575 |
4492 |
0.12 |
chr12_117857982_117858133 | 4.69 |
Cdca7l |
cell division cycle associated 7 like |
14169 |
0.2 |
chr9_59664998_59665149 | 4.68 |
Pkm |
pyruvate kinase, muscle |
271 |
0.87 |
chr9_13681735_13681905 | 4.68 |
Maml2 |
mastermind like transcriptional coactivator 2 |
19360 |
0.18 |
chr12_113118261_113118412 | 4.68 |
Mta1 |
metastasis associated 1 |
12996 |
0.1 |
chr4_101176228_101176401 | 4.66 |
Jak1 |
Janus kinase 1 |
9111 |
0.15 |
chr7_98002722_98002888 | 4.63 |
Gdpd4 |
glycerophosphodiester phosphodiesterase domain containing 4 |
44984 |
0.13 |
chr2_25558903_25559058 | 4.62 |
Edf1 |
endothelial differentiation-related factor 1 |
841 |
0.31 |
chr7_26304675_26304844 | 4.57 |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
2410 |
0.19 |
chr18_78126881_78127045 | 4.56 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
3537 |
0.29 |
chr5_121838276_121838548 | 4.55 |
Sh2b3 |
SH2B adaptor protein 3 |
766 |
0.47 |
chr8_84785963_84786162 | 4.54 |
Nfix |
nuclear factor I/X |
11693 |
0.1 |
chr4_41524935_41525096 | 4.50 |
Fam219a |
family with sequence similarity 219, member A |
245 |
0.85 |
chr5_146289990_146290309 | 4.49 |
Cdk8 |
cyclin-dependent kinase 8 |
3973 |
0.2 |
chr17_45699165_45699326 | 4.49 |
Mrpl14 |
mitochondrial ribosomal protein L14 |
3829 |
0.14 |
chr16_93793312_93793530 | 4.47 |
Dop1b |
DOP1 leucine zipper like protein B |
632 |
0.59 |
chr16_31996383_31996610 | 4.47 |
Hmgb1-ps6 |
high mobility group box 1, pseudogene 6 |
4628 |
0.09 |
chr6_71235183_71235374 | 4.47 |
Smyd1 |
SET and MYND domain containing 1 |
18404 |
0.1 |
chr6_116653898_116654072 | 4.46 |
Depp1 |
DEPP1 autophagy regulator |
3289 |
0.14 |
chr8_111148892_111149043 | 4.45 |
9430091E24Rik |
RIKEN cDNA 9430091E24 gene |
3487 |
0.18 |
chr7_142081836_142082027 | 4.45 |
Gm25416 |
predicted gene, 25416 |
3494 |
0.11 |
chr15_25942411_25942580 | 4.45 |
Retreg1 |
reticulophagy regulator 1 |
184 |
0.95 |
chr11_117249706_117249909 | 4.45 |
Gm16045 |
predicted gene 16045 |
13630 |
0.17 |
chr1_164714845_164715063 | 4.43 |
Gm36945 |
predicted gene, 36945 |
2413 |
0.25 |
chr14_65050597_65050753 | 4.42 |
Extl3 |
exostosin-like glycosyltransferase 3 |
47430 |
0.13 |
chr10_19585787_19585961 | 4.41 |
Ifngr1 |
interferon gamma receptor 1 |
6075 |
0.2 |
chr8_95166025_95166176 | 4.41 |
Kifc3 |
kinesin family member C3 |
16691 |
0.12 |
chr4_108015493_108015714 | 4.38 |
Slc1a7 |
solute carrier family 1 (glutamate transporter), member 7 |
5586 |
0.14 |
chr15_59054962_59055129 | 4.38 |
Mtss1 |
MTSS I-BAR domain containing 1 |
419 |
0.87 |
chr12_80218314_80218489 | 4.35 |
Gm47767 |
predicted gene, 47767 |
9158 |
0.15 |
chr6_136761842_136762027 | 4.34 |
Gucy2c |
guanylate cyclase 2c |
19808 |
0.11 |
chr12_72285376_72285556 | 4.32 |
Rtn1 |
reticulon 1 |
48742 |
0.15 |
chr19_36692056_36692224 | 4.32 |
Hectd2os |
Hectd2, opposite strand |
2661 |
0.32 |
chr5_34987481_34987632 | 4.30 |
Rgs12 |
regulator of G-protein signaling 12 |
1572 |
0.35 |
chr5_76063442_76063602 | 4.29 |
Gm6051 |
predicted gene 6051 |
2759 |
0.24 |
chr12_28698364_28698550 | 4.28 |
Trappc12 |
trafficking protein particle complex 12 |
3152 |
0.18 |
chr19_43440308_43440459 | 4.27 |
Cnnm1 |
cyclin M1 |
53 |
0.52 |
chr6_142451548_142451710 | 4.27 |
Gys2 |
glycogen synthase 2 |
21480 |
0.15 |
chr7_81453890_81454046 | 4.26 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
707 |
0.51 |
chr1_131716457_131716608 | 4.26 |
Rab7b |
RAB7B, member RAS oncogene family |
19894 |
0.14 |
chr3_149942137_149942288 | 4.24 |
Rpsa-ps10 |
ribosomal protein SA, pseudogene 10 |
131330 |
0.06 |
chr13_59767243_59767411 | 4.24 |
Isca1 |
iron-sulfur cluster assembly 1 |
2150 |
0.13 |
chr6_100734142_100734293 | 4.23 |
Gm15576 |
predicted gene 15576 |
7983 |
0.18 |
chr6_100014081_100014233 | 4.23 |
Gm33201 |
predicted gene, 33201 |
22942 |
0.2 |
chr18_38306714_38306870 | 4.22 |
Rnf14 |
ring finger protein 14 |
7040 |
0.11 |
chr2_152360517_152360697 | 4.22 |
Gm14165 |
predicted gene 14165 |
6992 |
0.09 |
chr7_26832827_26833002 | 4.21 |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
2391 |
0.25 |
chr1_78081905_78082084 | 4.21 |
Gm28387 |
predicted gene 28387 |
109618 |
0.06 |
chr8_122059112_122059293 | 4.20 |
Banp |
BTG3 associated nuclear protein |
58355 |
0.09 |
chr1_192181819_192181973 | 4.18 |
Kcnh1 |
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
8878 |
0.17 |
chr10_17551883_17552066 | 4.17 |
Gm47770 |
predicted gene, 47770 |
25060 |
0.17 |
chr2_49522677_49522856 | 4.15 |
Epc2 |
enhancer of polycomb homolog 2 |
6109 |
0.29 |
chr14_56558202_56558361 | 4.14 |
Cenpj |
centromere protein J |
5796 |
0.17 |
chr14_65033826_65033977 | 4.13 |
Extl3 |
exostosin-like glycosyltransferase 3 |
64204 |
0.09 |
chr18_77565630_77565809 | 4.11 |
Rnf165 |
ring finger protein 165 |
558 |
0.81 |
chr2_32673636_32673820 | 4.10 |
Eng |
endoglin |
362 |
0.62 |
chr11_62939124_62939275 | 4.10 |
Cdrt4os2 |
CMT1A duplicated region transcript 4, opposite strand 2 |
11880 |
0.13 |
chr13_101753788_101753966 | 4.10 |
Gm36638 |
predicted gene, 36638 |
672 |
0.73 |
chr8_94180066_94180232 | 4.09 |
Mt1 |
metallothionein 1 |
908 |
0.38 |
chr11_87448961_87449148 | 4.08 |
Rnu3b3 |
U3B small nuclear RNA 3 |
427 |
0.66 |
chr7_15980408_15980576 | 4.07 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
1767 |
0.22 |
chr4_55014920_55015072 | 4.06 |
Zfp462 |
zinc finger protein 462 |
3516 |
0.32 |
chr3_101805744_101805931 | 4.04 |
Mab21l3 |
mab-21-like 3 |
30386 |
0.17 |
chr12_5213695_5213866 | 4.03 |
Gm48532 |
predicted gene, 48532 |
22184 |
0.23 |
chr1_73513962_73514123 | 4.02 |
Gm9553 |
predicted gene 9553 |
1996 |
0.31 |
chr5_86084052_86084210 | 4.01 |
Stap1 |
signal transducing adaptor family member 1 |
2327 |
0.23 |
chr11_108198624_108198935 | 4.00 |
Gm11655 |
predicted gene 11655 |
16929 |
0.25 |
chrX_73730962_73731113 | 4.00 |
Abcd1 |
ATP-binding cassette, sub-family D (ALD), member 1 |
14297 |
0.09 |
chr5_144338257_144338450 | 3.99 |
Dmrt1i |
Dmrt1 interacting ncRNA |
19570 |
0.15 |
chr2_101827717_101827895 | 3.99 |
Prr5l |
proline rich 5 like |
11174 |
0.22 |
chr19_36731471_36731641 | 3.98 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
5097 |
0.23 |
chr17_85858174_85858325 | 3.97 |
Gm29418 |
predicted gene 29418 |
34205 |
0.19 |
chr14_63479379_63479556 | 3.96 |
Gm47074 |
predicted gene, 47074 |
4091 |
0.16 |
chr11_121099879_121100030 | 3.96 |
Gm11791 |
predicted gene 11791 |
2747 |
0.12 |
chr5_144248287_144248466 | 3.94 |
2900089D17Rik |
RIKEN cDNA 2900089D17 gene |
1870 |
0.23 |
chr2_152339123_152339274 | 3.93 |
Trib3 |
tribbles pseudokinase 3 |
4772 |
0.11 |
chr13_52150386_52150766 | 3.93 |
Gm48199 |
predicted gene, 48199 |
29835 |
0.18 |
chr7_49351868_49352264 | 3.93 |
Gm44913 |
predicted gene 44913 |
5972 |
0.24 |
chr8_71926704_71926863 | 3.92 |
Zfp617 |
zinc finger protein 617 |
3931 |
0.12 |
chr8_126309380_126309531 | 3.90 |
Slc35f3 |
solute carrier family 35, member F3 |
10897 |
0.27 |
chr7_110969269_110969430 | 3.90 |
Mrvi1 |
MRV integration site 1 |
12709 |
0.18 |
chr4_117116805_117116956 | 3.89 |
Ptch2 |
patched 2 |
3456 |
0.09 |
chr15_78803478_78803676 | 3.89 |
Card10 |
caspase recruitment domain family, member 10 |
535 |
0.64 |
chr1_88680837_88681020 | 3.89 |
Arl4c |
ADP-ribosylation factor-like 4C |
20948 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 7.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.4 | 4.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 3.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.2 | 2.5 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.2 | 3.7 | GO:0015817 | histidine transport(GO:0015817) |
1.2 | 5.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.2 | 8.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.0 | 1.0 | GO:0072262 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.9 | 4.6 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.9 | 3.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.9 | 4.5 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.9 | 3.6 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.8 | 2.5 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.8 | 4.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.8 | 2.5 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.8 | 2.4 | GO:0015755 | fructose transport(GO:0015755) |
0.8 | 3.1 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.8 | 4.6 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.7 | 3.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.7 | 5.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.7 | 2.2 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.7 | 3.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.7 | 2.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 2.8 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.7 | 2.7 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.7 | 2.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.7 | 0.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.7 | 2.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.7 | 2.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.7 | 1.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.6 | 1.3 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.6 | 1.9 | GO:0040031 | snRNA modification(GO:0040031) |
0.6 | 3.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.6 | 2.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 4.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 2.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 0.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 3.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 1.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 1.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.6 | 2.3 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.6 | 1.7 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.5 | 2.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 1.6 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.5 | 2.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.5 | 2.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.5 | 1.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.5 | 2.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.5 | 2.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.5 | 1.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.5 | 2.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 3.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.5 | 2.0 | GO:0050955 | thermoception(GO:0050955) |
0.5 | 1.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.5 | 1.0 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.5 | 1.9 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.5 | 1.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 1.4 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 1.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 1.4 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.5 | 1.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.5 | 0.9 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.5 | 2.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.5 | 1.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 1.4 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.5 | 1.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.4 | 1.3 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.4 | 1.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 1.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.4 | 2.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 2.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 2.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 2.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 1.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.4 | 2.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 0.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 0.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 2.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 1.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.4 | 5.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 2.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 1.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 1.6 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 1.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.4 | 1.9 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.4 | 1.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 2.3 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 1.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 1.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.4 | 1.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 0.4 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.4 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 0.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 1.8 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 1.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 1.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.4 | 1.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.4 | 1.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.4 | 0.7 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.4 | 0.7 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 3.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 1.0 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.3 | 0.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.3 | 0.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 0.7 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.3 | 1.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 1.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 1.7 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.3 | 1.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.3 | 1.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.3 | 1.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.3 | 1.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.3 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 1.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.3 | 10.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 0.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 0.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 0.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.3 | 1.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.3 | 1.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 2.8 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.3 | 0.9 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 0.6 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.3 | 1.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.3 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.3 | 0.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 1.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 1.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 0.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.3 | 0.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 1.8 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.8 | GO:0051180 | vitamin transport(GO:0051180) |
0.3 | 0.9 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 1.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 0.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 0.3 | GO:1904851 | scaRNA localization to Cajal body(GO:0090666) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.3 | 0.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.3 | 1.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 2.9 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 0.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.3 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.8 | GO:0070268 | cornification(GO:0070268) |
0.3 | 0.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 1.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 0.6 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.3 | 0.6 | GO:0001705 | ectoderm formation(GO:0001705) |
0.3 | 3.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.3 | 1.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 2.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 2.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 2.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 0.8 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 1.6 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.8 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 1.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 1.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.8 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.3 | 0.8 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 2.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.3 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.3 | 2.9 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.3 | 1.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.3 | 1.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 2.4 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 1.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 3.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 0.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 1.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.0 | GO:2000644 | regulation of receptor catabolic process(GO:2000644) |
0.3 | 0.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 1.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.5 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.3 | 1.8 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 2.5 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 0.5 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.3 | 0.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 1.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 2.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 2.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.2 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.2 | 1.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 0.5 | GO:0048793 | pronephros development(GO:0048793) |
0.2 | 1.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 2.2 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.2 | 1.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.2 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 2.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.2 | 1.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.7 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 4.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 1.6 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 2.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.2 | 0.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 2.0 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 1.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.9 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.2 | 0.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 0.2 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.2 | 0.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.7 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.9 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.4 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 2.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.4 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 1.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 1.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.6 | GO:0034447 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 1.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.4 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 1.9 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 1.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 1.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.2 | 2.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 2.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 1.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 1.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.2 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 2.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 1.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 1.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 1.4 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 1.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 0.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.6 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.4 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.2 | 1.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 1.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.2 | 0.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.8 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.4 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 0.6 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.8 | GO:0015879 | carnitine transport(GO:0015879) |
0.2 | 0.9 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.2 | 0.6 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 0.6 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.2 | 1.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.2 | 0.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.6 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.5 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 4.6 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 1.5 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 4.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.7 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.8 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.2 | 0.2 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.2 | 7.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.2 | 0.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.2 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 1.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 0.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 0.4 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.2 | 1.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.1 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.2 | 1.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.7 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.2 | 0.4 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 1.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 2.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 4.2 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.2 | 0.9 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 0.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.2 | 0.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.2 | 1.0 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 1.7 | GO:0070166 | enamel mineralization(GO:0070166) |
0.2 | 0.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 1.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 1.0 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.2 | 0.2 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.2 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 1.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.2 | 1.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 1.4 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.2 | 0.5 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 0.5 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.2 | 1.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 1.0 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.9 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
0.2 | 0.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 0.8 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.2 | 0.6 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.2 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.5 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.2 | 1.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 2.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.2 | 0.5 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 0.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.6 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.2 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.3 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.2 | 2.0 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.2 | 0.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 0.5 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.4 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.1 | 1.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 2.5 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.7 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.1 | 0.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.1 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.1 | 0.7 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 4.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.7 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.4 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.6 | GO:0051561 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.6 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 1.8 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.4 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.4 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.4 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.4 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.1 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.1 | 0.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 1.4 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 2.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.1 | GO:0002739 | regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 1.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 1.9 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.6 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.2 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 0.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 3.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 1.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 1.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 1.6 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.1 | 0.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.1 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.6 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.5 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 0.9 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.3 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.3 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 | 0.1 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.1 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.1 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.1 | 0.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 1.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 1.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 4.7 | GO:0022404 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.7 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.9 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.1 | 0.5 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.5 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.3 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.1 | 0.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.1 | 0.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.1 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.1 | 1.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 2.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0055094 | Cdc42 protein signal transduction(GO:0032488) regulation of Cdc42 protein signal transduction(GO:0032489) response to lipoprotein particle(GO:0055094) |
0.1 | 0.2 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 1.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.3 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 2.4 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.1 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.3 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.4 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.4 | GO:0018214 | protein carboxylation(GO:0018214) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.5 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 4.7 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.1 | 0.2 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 0.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 1.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.1 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) |
0.1 | 1.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 1.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 0.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.6 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.3 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 2.6 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.1 | 0.2 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 0.4 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.3 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.5 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.1 | 0.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.7 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.1 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.1 | 1.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.1 | 0.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.2 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.5 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.3 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 1.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.1 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 0.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.8 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.3 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.1 | 0.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.1 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 1.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.6 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.2 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 0.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 0.8 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.1 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.1 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.1 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.4 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 2.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.1 | 0.8 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.4 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.1 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.1 | 0.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.1 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.1 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.4 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.1 | 1.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 3.6 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.1 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.1 | 0.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.1 | 0.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 0.3 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.1 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.5 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.0 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.0 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 2.3 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.3 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 1.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.1 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.1 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.1 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.0 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.0 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.2 | GO:0010518 | positive regulation of phospholipase activity(GO:0010518) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.0 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.3 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.0 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.0 | 0.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.0 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.4 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 0.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.3 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.4 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.3 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 2.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.2 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.0 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.0 | 0.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.0 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.0 | 0.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.2 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.6 | GO:0001662 | behavioral fear response(GO:0001662) fear response(GO:0042596) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.3 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.5 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.0 | 0.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.2 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.1 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.0 | 0.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 1.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.0 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.0 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.0 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.3 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.1 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.0 | 0.0 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.0 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.0 | 0.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.0 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.0 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.1 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 1.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.0 | 0.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.0 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.0 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 1.5 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.0 | 0.0 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.0 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.0 | 0.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.0 | 0.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.0 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.0 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.0 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.0 | 0.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) inter-male aggressive behavior(GO:0002121) |
0.0 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.0 | GO:0097154 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.0 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.1 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.0 | 0.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.0 | 0.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.3 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.0 | 0.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0051645 | Golgi localization(GO:0051645) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.0 | 0.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 0.0 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 1.3 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.0 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.0 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.0 | GO:0044766 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.1 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.0 | GO:0070633 | transepithelial transport(GO:0070633) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 2.9 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 2.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 2.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.9 | 2.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.9 | 3.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.8 | 4.5 | GO:0016589 | NURF complex(GO:0016589) |
0.7 | 0.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.7 | 4.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.6 | 3.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 2.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.6 | 1.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 2.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 1.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.6 | 7.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 1.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.6 | 1.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 9.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 4.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 1.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 1.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 2.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.4 | 1.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 1.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 1.4 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 1.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.3 | 0.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 2.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 1.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 1.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 2.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 2.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.1 | GO:0044308 | axonal spine(GO:0044308) |
0.3 | 1.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 0.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.3 | 2.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 1.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 1.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.8 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 2.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.8 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.6 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 2.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 2.7 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 2.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 3.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.8 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 1.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 2.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.1 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.7 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 8.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 7.2 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 2.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 1.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.3 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 1.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 1.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 1.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.9 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 2.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 4.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 2.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 2.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 4.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.6 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 6.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 1.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.6 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.1 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.3 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.4 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.4 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.1 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 1.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.1 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.7 | GO:0031674 | I band(GO:0031674) |
0.1 | 0.6 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 3.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.1 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.8 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 0.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.4 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.8 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 3.1 | GO:0016605 | PML body(GO:0016605) |
0.1 | 14.5 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.3 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 1.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 1.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 3.9 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 1.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0034702 | ion channel complex(GO:0034702) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.3 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 3.2 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 27.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 1.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 1.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.2 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 1.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.5 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.4 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 1.9 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.0 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.1 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.0 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.0 | 0.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.0 | 0.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 1.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.0 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0030519 | snoRNP binding(GO:0030519) |
1.0 | 4.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.0 | 4.1 | GO:0031433 | telethonin binding(GO:0031433) |
1.0 | 3.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.0 | 4.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.0 | 2.9 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.9 | 3.7 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.9 | 4.5 | GO:0043426 | MRF binding(GO:0043426) |
0.9 | 2.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.8 | 2.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.8 | 2.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 2.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 2.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.7 | 2.2 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 5.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.7 | 4.2 | GO:0043559 | insulin binding(GO:0043559) |
0.7 | 2.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 2.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.7 | 2.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 1.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.6 | 1.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 2.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.6 | 1.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.6 | 1.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.6 | 1.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 3.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 2.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.5 | 2.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.5 | 1.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.5 | 1.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 2.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 5.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 2.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 0.5 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.4 | 1.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 4.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 3.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 2.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 5.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 2.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.4 | 3.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 0.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 1.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 0.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 1.1 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 6.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 12.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 2.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 1.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 2.0 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 1.6 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 1.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 0.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.3 | 0.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 0.9 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 0.9 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.3 | 1.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.3 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 0.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 3.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 2.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 3.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 2.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 0.9 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 4.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 0.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 1.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 2.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 0.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 1.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.3 | 4.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 2.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 2.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 3.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 1.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 0.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 0.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 3.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 2.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 3.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 6.0 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 1.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 1.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 7.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 1.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 3.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 2.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 1.9 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 2.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 1.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 2.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 2.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 2.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.9 | GO:0018448 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.8 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 1.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 2.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 3.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 1.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 2.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.6 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 3.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 2.8 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.9 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.2 | 1.6 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.2 | 0.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 0.7 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 3.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.5 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 2.3 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.2 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 2.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 2.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 1.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 2.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 1.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.2 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.2 | 0.8 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 1.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 0.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.6 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.2 | 1.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 0.8 | GO:0052760 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 1.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 6.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 2.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.9 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 1.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 6.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 4.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 1.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 1.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 2.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 7.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 5.2 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.5 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 3.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 1.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 2.3 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 3.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.9 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 1.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 3.2 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 1.3 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 3.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 3.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 2.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.8 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 1.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 7.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 1.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 2.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 1.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 1.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 1.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.1 | GO:1904680 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.1 | 1.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 2.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 4.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 3.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.2 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 4.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.3 | GO:0016886 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.0 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 7.6 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 9.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.0 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.4 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.1 | 3.0 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 1.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 4.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 1.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 1.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 1.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 1.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.9 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 2.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.4 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.6 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 2.8 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 1.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.0 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.0 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.6 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 1.6 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 1.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 3.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.0 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.0 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 1.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.0 | 0.0 | GO:0009975 | cyclase activity(GO:0009975) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 1.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.0 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.3 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 1.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 4.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 2.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 16.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 1.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 4.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 5.1 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 4.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 3.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 3.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 2.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 6.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 2.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 4.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 3.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 6.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 3.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 2.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 2.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 2.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 2.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.3 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 4.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 9.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 3.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 2.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.5 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.6 | 6.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 5.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 0.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.4 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 0.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 6.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 5.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 6.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 3.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 2.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 4.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 2.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 3.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 2.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 5.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 2.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 4.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 4.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 1.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 2.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.9 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 1.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 2.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.8 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 2.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.1 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.1 | 1.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 2.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 5.6 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 1.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 7.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 2.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.4 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 1.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 6.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 5.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 1.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 3.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 1.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 2.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 0.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |